http://cancer-metabolism-summit.com/
World Cancer Metabolism Summit Translating the Revival of Warburg into Commercial Drug Development
1 - 2 February 2012
Washington, D.C.
About
With millions of dollars of investment from pharmaceutical giants, this meeting focuses on the exciting research field that everyone is watching: cancer metabolism.
Given the pharmaceutical industry’s heavy investment into the research of
cancer metabolism, now is the perfect time to come together to cash in on the benefits of
cancer starving drugs. Seize your chance to take part in the fast growing community which is translating the
Warburg phenomenon into a new generation of cancer therapies.
Sharing
strategies and
approaches to
drug discovery will play a vital step in your company’s progression of metabolic targeting cancer drugs. With large pharma and leading biotechs now ready to
reveal those techniques there has never been a meeting so focused on pushing metabolic targeting drugs into the clinic and through to the market.
With the agenda designed by cutting edge research with experts at
GSK,
AstraZeneca,
Genentech,
Myrexis, Cornerstone and
Warburg Glycomed, the
World Cancer Metabolism summit is unchallenged in its industry relevance. It is designed to be specific and relevant to
cancer metabolism and will deliver solutions to current issues faced by drug developers.